Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH is an Fmoc-protected amino acid derivative where L-serine is glycosylated at the side-chain hydroxyl with a β-D-GlcNAc bearing three acetyl substituents, yielding a serine-glycoside conjugate suitable for peptide-related synthesis. The molecule contains an Fmoc carbamate protecting group on the amino functionality, a free carboxylic acid (-COOH) at the α-position, and an anomeric β-linked N-acetylglucosamine unit whose acylated hydroxyls (acetate esters) modulate polarity and hydrogen-bonding behavior while preserving the glycosidic linkage. In research workflows, it is used as a protected, structurally defined building block for assembling glycoamino acid motifs in peptides or glycoconjugate constructs, including solid-phase or solution-phase strategies that require chemoselective handling of the amino group and controlled presentation of the acetylated sugar side chain.
CAT No: CP25416
CAS No:160067-63-0
Synonyms/Alias:160067-63-0;Fmoc-L-Ser(|A-D-GlcNAc(Ac)3)-OH;Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH;(2S)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid;L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-;O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-N-FMOC-L-SERINE;(2S)-3-{[(2R,3R,4R,5S,6R)-4,5-BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]-3-ACETAMIDOOXAN-2-YL]OXY}-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}PROPANOIC ACID;FmocSer(Ac3-?-D-GlcNAc)-OH;ORICVOOXZDVFIP-ILRBKQRBSA-N;EX-A3855;Fmoc-Ser(beta-D-GlcNAc(Ac)3)-OH;AKOS027250759;HY-104004A;MA04454;Fmoc-L-Ser((Ac)?-|A-D-GlcNAc)-OH;Fmoc-L-Ser((Ac)3-|A-D-GlcNAc)-OH;Fmoc-L-Ser((Ac)3-beta-D-GlcNAc)-OH;(2s)-3-{[(2r,3r,4r,5s,6r)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2h-pyran-2-yl]oxy}-2-{[(9h-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid;DA-53323;CS-0103206;A12113;2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-?-D-glucopyranosyl-Fmoc serine;O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-?-D-glucopyranosyl)-N-Fmoc-L-serine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-ss-D-glucopyranosyl]-L-serine; FmocSer(Ac3-ss-D-GlcNAc)-OH; O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-ss-D-glucopyranosyl)-N-(fluoren-9-yl-methoxycarbonyl)-L-serine;O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-N-ALPHA-(FLUOREN-9-YL-METHOXY CARBONYL)-L-SERINE;O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-N-alpha-(fluoren-9-yl-methoxycarbonyl)-L-serine;
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-serine
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH is an Fmoc-protected L-serine glycosylated at the side-chain hydroxyl with a β-D-GlcNAc bearing three acetyl groups, forming a stable N-acetylated sugar motif while preserving the serine stereocenter. The molecule contains an Fmoc carbamate for orthogonal N-protection during peptide assembly, a free carboxylic acid for C-terminal coupling, and multiple acetamide/ester functionalities on the protected glycan that modulate polarity and reactivity. Acetylated sugar groups can participate in controlled deprotection sequences, enabling downstream conversion to less protected glycoforms without disturbing the peptide-compatible backbone. The combination of a peptide-building-block core with a protected carbohydrate side chain makes the compound suitable as a chiral intermediate for glycopeptide construction and as a defined structural reagent for glycan-mediated recognition studies.
1. Glycopeptide Synthesis
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH is used in peptide synthesis workflows to install a glycosylated serine residue with β-linkage geometry at the side-chain position. The Fmoc group enables stepwise N-terminal protection and deprotection under peptide-manufacturing conditions, while the serine carboxylic acid supports standard amide-bond formation during chain elongation. The acetyl-protected GlcNAc side chain functions as a protected glycan handle that can remain stable through coupling steps, then be transformed via selective deacetylation strategies to access defined glycoforms. The resulting glycopeptide products can serve as structural standards, substrate analogs, or scaffold components for mapping glycan-dependent sequence effects in peptide science.
2. Chemical Biology Probes
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH supports chemical biology research where defined N-acetylglucosamine presentation is required for studying carbohydrate recognition. The β-D-GlcNAc(Ac)3 motif provides multiple hydrogen-bonding and acetamide-associated interaction features that can be preserved during conjugation or peptide incorporation, while the serine linkage positions the sugar in a peptide-like spatial context. The protected acetyl groups can be maintained to tune solubility and minimize premature glycan reactivity, then removed to generate a more native-like GlcNAc surface for binding assays or receptor engagement studies. Downstream glycopeptide or glycan-decorated constructs derived from this building block can be applied to probe lectin specificity, glycosidase processing, or glycan-mediated molecular interactions.
3. Bioconjugation Chemistry
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH can be employed as a glycosylated amino acid intermediate for constructing conjugates that display controlled carbohydrate density and stereochemistry. The molecule's protected glycan framework enables sequential functionalization routes, where acetyl groups can be used as temporary protecting groups to manage reactivity during linker installation or coupling to biomolecule carriers. The Fmoc-protected nitrogen and the terminal carboxyl group allow incorporation into peptide-based linkers or solid-phase assembled constructs that later undergo deprotection to expose the glycan for conjugation-ready formats. Glycoconjugates generated from this intermediate can be used in analytical research, affinity reagent development, and material-facing biochemical studies requiring reproducible β-GlcNAc presentation.
4. Protected Amino Acid Building Block
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH functions as a protected amino acid derivative designed for orthogonal compatibility in peptide building-block preparation. The Fmoc carbamate provides N-protection for controlled deprotection cycles, while the serine side-chain hydroxyl is converted into a glycosidic substituent, preventing side reactions that would otherwise compete with peptide coupling. The acetylated sugar acts as a protecting-group set that can be carried through peptide assembly, reducing undesired participation of hydroxyl groups in side reactions and improving handling of the polar glycan. The defined stereochemistry at the L-serine center and the β-anomeric configuration of the GlcNAc unit support reproducible construction of glycopeptide libraries and process-oriented synthesis of carbohydrate-bearing intermediates.
5. Pharmaceutical Intermediate Preparation
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH is applicable to pharmaceutical intermediate preparation where glycosylated peptide segments are manufactured as defined building blocks for downstream formulation of glycoengineered molecules. The presence of an Fmoc-protected amine and a free carboxylic acid aligns with industrial peptide-coupling chemistry used to generate amide-linked intermediates under controlled protection/deprotection schemes. The acetylated GlcNAc side chain can be used to manage functional group tolerance during manufacturing steps, then converted to deacetylated glycoforms when a more native-like carbohydrate is required for subsequent transformations. The compound's structure enables consistent generation of glycopeptide intermediates for process chemistry development, analytical method qualification, and specialty chemical production routes that require stereodefined carbohydrate-bearing fragments.
6. Fine Chemical Synthesis and Process Chemistry
Fmoc-L-Ser(beta-D-GlcNAc(Ac)3)-OH can be utilized in fine chemical synthesis and process chemistry as a chiral glycosylated intermediate for constructing complex amino acid derivatives. The combination of a chiral amino acid core, a protected carbohydrate side chain, and orthogonally removable protecting groups supports route design where selective transformations occur without disrupting the peptide-compatible functionality. The acetyl groups on the GlcNAc unit enable controlled modification of polarity and reactivity, supporting manufacturing workflows that require predictable handling and minimized side-product formation from free hydroxyl groups. Downstream derivatives prepared from this intermediate, including deacetylated glycoforms, glycan-functionalized peptide analogs, and glycosylated standards for analytical research, can be generated with stereochemical fidelity consistent with applied amino acid chemistry and industrial intermediate preparation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.